Internationalising to create firm specific advantages: leapfrogging strategies of U.S. pharmaceutical firms in the 1930s and 1940s & Indian pharmaceutical firms in the 1990s and 2000s

S. Athreye and A. Godley

No 51, MERIT Working Papers from United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT)

JEL-codes: O25 (search for similar items in EconPapers)
Date: 2016-03-30
References: Add references at CitEc
Citations:

Downloads: (external link)
https://cris.maastrichtuniversity.nl/ws/files/3232 ... 6832650-ASSET1.0.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:unm:unumer:2007051

Access Statistics for this paper

More papers in MERIT Working Papers from United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT) Contact information at EDIRC.
Bibliographic data for series maintained by Ad Notten ( this e-mail address is bad, please contact ).